Patient Advisory Committee
Patients and the vision to advance more patient-centred, personalised treatment options are at the heart of the 3TR endeavour.
From the beginning, a Patient Advisory Committee (PAC) was established to ensure that the voices of people living with one of the seven diseases 3TR investigates are heard and integrated into the project’s research activities—within and across the different disease working groups.
The PAC is a diverse group consisting of people with chronic autoimmune, inflammatory bowel or respiratory diseases, alongside representatives of the medical association European Respiratory Society (ERS), as well as members of the patient organisations Lupus Europe, the European Lung Foundation (ELF), and the European Federation of Allergy Airways Diseases Patients’ Association (E.F.A.).
Together, they bring in a wide range of patient perspectives, helping researchers and clinicians understand and gain insights from their experience, thus serving as an essential advisory resource.